
Hiddo Heerspink, PhD, discusses finerenone data in type 1 diabetes, FSGS and IgA nephropathy, and open questions on sequencing CKD therapies.
The American Journal of Managed Care
over 29 years ago
The Three Dimensions of Managed Care Pharmacy Practiceover 29 years ago
Hospitals and Managed Care: Catching Up with the Networks





